Glutamate transporters: animal models to neurologic disease

被引：285

作者：

Maragakis, NJ ^{[1
]}

Rothstein, JD ^{[1
]}

机构：

[1] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA

来源：

NEUROBIOLOGY OF DISEASE | 2004年 / 15卷 / 03期

关键词：

glutamate; central nervous system; neurologic diseases;

D O I：

10.1016/j.nbd.2003.12.007

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：461 / 473

页数：13

共 97 条

[21]

GINSBERG SD, 1995, J NEUROCHEM, V65, P2800

[22] Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice [J].

Guo, H ;

Lai, LC ;

Butchbach, MER ;

Stockinger, MP ;

Shan, X ;

Bishop, GA ;

Lin, CLG .

HUMAN MOLECULAR GENETICS, 2003, 12 (19) :2519-2532

[23] MOTOR-NEURON DEGENERATION IN MICE THAT EXPRESS A HUMAN CU,ZN SUPEROXIDE-DISMUTASE MUTATION [J].

GURNEY, ME ;

PU, HF ;

CHIU, AY ;

DALCANTO, MC ;

POLCHOW, CY ;

ALEXANDER, DD ;

CALIENDO, J ;

HENTATI, A ;

KWON, YW ;

DENG, HX ;

CHEN, WJ ;

ZHAI, P ;

SUFIT, RL ;

SIDDIQUE, T .

SCIENCE, 1994, 264 (5166) :1772-1775

[24] Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia [J].

Hamann, M ;

Rossi, DJ ;

Marie, H ;

Attwell, D .

EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 15 (02) :308-314

[25] Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes [J].

Hazell, AS ;

Pannunzio, P ;

Rao, KVR ;

Pow, DV ;

Rambaldi, A .

GLIA, 2003, 43 (02) :175-184

[26] Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke's encephalopathy [J].

Hazell, AS ;

Rao, KVR ;

Danbolt, NC ;

Pow, DV ;

Butterworth, RF .

JOURNAL OF NEUROCHEMISTRY, 2001, 78 (03) :560-568

[27]

Hazell AS, 1997, J NEUROCHEM, V68, P2216

[28] Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) [J].

Howland, DS ;

Liu, J ;

She, YJ ;

Goad, B ;

Maragakis, NJ ;

Kim, B ;

Erickson, J ;

Kulik, J ;

DeVito, L ;

Psaltis, G ;

DeGennaro, LJ ;

Cleveland, DW ;

Rothstein, JD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) :1604-1609

[29] β-amyloid enhances glial glutamate uptake activity and attenuates synaptic efficacy [J].

Ikegaya, Y ;

Matsuura, S ;

Ueno, S ;

Baba, A ;

Yamada, MK ;

Nishiyama, N ;

Matsuki, N .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32180-32186

[30] The expression of escitatory amino acid transporter 2 (EAAT2) in forensic autopsy cases [J].

Ikematsu, K ;

Tsuda, R ;

Orihara, Y ;

Nakasono, T .

FORENSIC SCIENCE INTERNATIONAL, 2001, 118 (01) :49-55

← 1 2 3 4 5 6 7 8 9 10 →